News & Analysis as of

Life Sciences Series A

Latham & Watkins LLP

Fast Track to IPO: Why Are Series A Startups Snatching Topflight CFOs?

Latham & Watkins LLP on

Startups and scale-ups in Europe’s tech and life sciences sectors have flourished dramatically over the past year, fueled by pandemic-induced demand and a wall of investor cash. Early funding rounds are getting bigger, while...more

Goodwin

Leasing Models in Life Sciences and How They Correspond to the Life Cycle of a Company

Goodwin on

The real estate needs of life sciences companies can be fluid and complex, with early stage companies typically needing smaller flexible space and later stage companies typically requiring larger build-to-suit space. With an...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: Atreca Secures $56 Million in Funding

McGuireWoods LLP on

Atreca has announced it has secured $56 million in series A funding. Atreca, based in Redwood City, California, is a privately held biotechnology company developing therapeutics drawn from human immune responses,...more

Foley Hoag LLP

Quarterly Review of Seed, Series A and Series B/Later Round Financings: First Quarter 2015

Foley Hoag LLP on

The Numbers - Venture financing activity in New England decreased modestly in the first quarter of 2015 (-12%) with Seed and B/ Later round activity each decreasing by roughly 20% over Q4 2014. Despite this overall...more

Foley Hoag LLP

Venture Perspectives: Fourth Quarter 2014

Foley Hoag LLP on

The Numbers - Venture financing activity in New England increased modestly in the fourth quarter of 2014, with Seed and B/Later round activity increasing by 40% and 26%, respectively, over Q3 2014. For the second...more

Foley Hoag LLP

Venture Perspectives - March 2013: Quarterly Review of Seed, Series A and Series B/Later Round Financings: Fourth Quarter and Year...

Foley Hoag LLP on

In This Issue: - Activity Level of 2012 New England Transactions - All Rounds - Activity Level of New England Seed Transactions - Activity Level of New England Series A Transactions - Activity...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide